Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-08-017890
Filing Date
2008-03-13
Accepted
2008-03-13 11:23:24
Documents
2
Period of Report
2008-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11831
2 POA DOCUMENT poa.txt EX-24.3_231164 4345
  Complete submission text file 0001209191-08-017890.txt   18034
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Issuer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 225 SUMMIT AVENUE MONTVALE NJ 07645
Business Address 201-930-3835
Kirk Sigurd (Reporting) CIK: 0001429125 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09860 | Film No.: 08685305